Skip to content
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Contact Us
Menu
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Contact Us
Search
Close
A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

  • Post author:gtmrick
  • Post published:June 13, 2015
  • Post category:Uncategorized

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All. Continue reading at Motherboard Vice.

You Might Also Like

Vasomune is Pleased to Announce the Government of Canada’s Investment in AV-001 Targeting COVID-19

Vasomune is Pleased to Announce the Government of Canada’s Investment in AV-001 Targeting COVID-19

March 17, 2021

The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS)

March 20, 2020
Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

February 26, 2020

Recent Posts

  • Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease
  • Vasomune Announces Government Financial Support for the Development of COVID-19 Therapeutic
  • Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy
  • Vasomune is Pleased to Announce the Government of Canada’s Investment in AV-001 Targeting COVID-19
  • Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment

Recent Comments

    Archives

    • January 2022
    • November 2021
    • March 2021
    • December 2020
    • November 2020
    • August 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • August 2018
    • December 2017
    • June 2015

    Categories

    • Press Release
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About

    Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

    Vasomune Therapeutics 2020 © All Rights Reserved.